Sand Grove Capital Management’s Hologic HOLX Stock Holding History

Sand Grove Capital Management’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-377,962	Closed	-$28.2M	–	25
2025 Q4	$28.2M	Buy	+377,962	New	+$27.6M	9.54%	4

Other funds holding HOLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Sand Grove Capital Management's HOLX Position: Q1 2026 in Review

Sand Grove Capital Management sold out of Hologic (HOLX) in Q1 2026, closing a stake of 377,962 shares — an estimated $28.2M sold.

Sand Grove Capital Management first reported a position in HOLX in Q4 2025 and held it in 1 quarter. The position peaked at $28.2M in Q4 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

Sand Grove Capital Management reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
Sand Grove Capital Management sold 377,962 Hologic shares in Q1 2026, an estimated $28.2M.
Sand Grove Capital Management first reported a position in Hologic in Q4 2025 and held it in 1 quarter.
Sand Grove Capital Management's Hologic position peaked at $28.2M in Q4 2025.
704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Sand Grove Capital Management's 13F filing for Q1 2026, filed 15 May 2026.